Alvotech SA ALVO
$3.93
โผ -1.18% 24H
About
Alvotech S.A. is a global biopharmaceutical company specializing in the development, manufacturing, and delivery of high-quality biosimilar medicines. Biosimilars are biologic products highly similar to approved reference medicines, designed to expand patient access to affordable treatments for conditions in areas suchโฆ
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryLuxembourg
Employees1,012
TickerALVO
Statistics
Market Cap$1.23B
Revenue (TTM)$533.5M
Net Incomeโ
Net Marginโ
EPSโ
P/E42.40
P/S2.30
P/B-4.64
EV/EBITDA25.77
ROE-9.8%
Dividend Yieldโ
Price$3.93
Data: Twelve Data ยท Revenue = mcap / P/S